𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Re: Estimating the Benefits of PSA Screening

✍ Scribed by Monique J. Roobol; Fritz H. Schröder

Book ID
113611662
Publisher
Elsevier Science
Year
2010
Tongue
English
Weight
107 KB
Volume
57
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Instrumental variables when evaluating s
Instrumental variables when evaluating screening trials: estimating the benefit of detecting cancer by screening
✍ Martin W. McIntosh 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 3 views

When evaluating the bene"t of detecting cancer by screening we try to answer the question, &what would a screen detected subject's outcome have been if his/her cancer had progressed to clinical detection'. By &outcome' we mean survival time, cancer size and stage, lead time e!ects and more. Because

An Estimate of the Variance of Estimator
An Estimate of the Variance of Estimators for Lead Time and Screening Benefit Time in Randomized Cancer Screening Trials
✍ Karen Kafadar; Philip C. Prorok; Paul J. Smith 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 3 views

Variance estimators are derived for estimators of the average lead time and average benefit time due to screening in a randomized screening trial via influence functions. The influence functions demonstrate that these estimators are asymptotically equivalent to the mean difference, between the study